Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Siemens/TransScan

This article was originally published in The Gray Sheet

Executive Summary

Siemens/TransScan: Strategic partnership between the firms will include distribution of TransScan Research & Development's TS-2000 non-invasive breast impedance scanner and the joint development of detection devices for other forms of cancer using each firm's proprietary technologies. FDA's Radiological Devices Panel recommended Nov. 17 that a premarket approval application for the TS-2000 system was not approvable because data did not support the use of the device as an adjunct to mammography screening in the clinical setting ("The Gray Sheet" Nov. 24, p. 5)...

You may also be interested in...



Cosmetics Weekly Trademark Review: 14 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.

Cosmetics Weekly Trademark Review: 7 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.

OTC Codeine Is 'Safe And Effective' – UK Industry Responds To BBC Exposé

Will the UK follow other countries and reverse-switch codeine to prescription-only status? British industry association, the PAGB, responds to a BBC documentary questioning the safety and efficacy of OTC codeine.
UsernamePublicRestriction

Register

MT009313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel